[{"id":"a4cae95d-8294-4b6d-9760-55b3f0b7dc5d","acronym":"","url":"https://clinicaltrials.gov/study/NCT03762447","created_at":"2021-01-18T18:29:16.934Z","updated_at":"2024-07-02T16:35:27.834Z","phase":"Phase 1","brief_title":"A Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB086550 in Participants With Advanced Solid Tumors","source_id_and_acronym":"NCT03762447","lead_sponsor":"Incyte Corporation","biomarkers":" MSI","pipe":" | ","alterations":" MSI-H/dMMR","tags":["MSI"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSI-H/dMMR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e INCB86550"],"overall_status":"Completed","enrollment":" Enrollment 138","initiation":"Initiation: 12/10/2018","start_date":" 12/10/2018","primary_txt":" Primary completion: 11/17/2023","primary_completion_date":" 11/17/2023","study_txt":" Completion: 11/17/2023","study_completion_date":" 11/17/2023","last_update_posted":"2023-11-29"}]